A detailed history of Financial Insights, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Financial Insights, Inc. holds 3,057 shares of DXCM stock, worth $213,225. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,057
Holding current value
$213,225
% of portfolio
0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$59.83 - $87.57 $182,900 - $267,701
3,057 New
3,057 $266,000
Q2 2024

Jul 16, 2024

BUY
$110.31 - $140.45 $235,842 - $300,282
2,138 New
2,138 $242,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Financial Insights, Inc. Portfolio

Follow Financial Insights, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Insights, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Insights, Inc. with notifications on news.